CD276 and prostate carcinoma: Additionally, immunoblotting results depicted that CD276 was highly expressed in prostate cancer cell lines relative to RWPE-1 cells, and the highest expression was found in PC-3 cells (Figure 3i and Supplementary Figure S1C).